Cancers, Vol. 10, Pages 220: Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

Cancers, Vol. 10, Pages 220: Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

Cancers doi: 10.3390/cancers10070220

Authors: Kevin Washetine Simon Heeke Christelle Bonnetaud Mehdi Kara-Borni Marius Ilié Sandra Lassalle Catherine Butori Elodie Long-Mira Charles Hugo Marquette Charlotte Cohen Jérôme Mouroux Eric Selva Virginie Tanga Coraline Bence Jean-Marc Félix Loic Gazoppi Taycir Skhiri Emmanuelle Gormally Pascal Boucher Bruno Clément Georges Dagher Véronique Hofman Paul Hofman

Lung cancer is the major cause of death from cancer in the world and its incidence is increasing in women. Despite the progress made in developing immunotherapies and therapies targeting genomic alterations, improvement in the survival rate of advanced stages or metastatic patients remains low. Thus, urgent development of effective therapeutic molecules is needed. The discovery of novel therapeutic targets and their validation requires high quality biological material and associated clinical data. With this aim, we established a biobank dedicated to lung cancers. We describe here our strategy and the indicators used and, through an overall assessment, present the strengths, weaknesses, opportunities and associated risks of this biobank.

https://ift.tt/2IDiz7l